The regulation of Wnt/β-catenin such as Wnt1, Wnt4 and β-catenin and PI3K/AKT pathways by adiponectin contributes to the improvement of VC in patients with uremia (Ponnusamy et al. 2018; He et al. 2019). Here, ADIPOQ is linked to uremia.